Progression-free, disease-free, and recurrence-free survivals as surrogate in melanoma perioperative immune checkpoint inhibitor trials.
Not Applicable
- Conditions
- Malignant melanoma
- Registration Number
- JPRN-UMIN000054048
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Perioperative ICI combined with radiological treatment will be excluded.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method